US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Vyome Holdings, Inc.

2.20

+0.280014.58%

Pre-market: 2.17-0.0300-1.36%04:20 EST

Volume:1.35M

Turnover:2.78M

Market Cap:12.42M

PE:-0.01

High:2.21

Open:1.86

Low:1.75

Close:1.92

52wk High:376.50

52wk Low:1.75

Shares:5.64M

Float Shares:3.10M

Volume Ratio:0.15

T/O Rate:43.46%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-183.1419

EPS(LYR):-0.7646

ROE:--

ROA:-24.52%

PB:4.91

PE(LYR):-2.88

Loading ...

Overview Company News Filings

Vyome Holdings Inc. Files Initial Beneficial Ownership Statement; Director Shiladitya Sengupta Named as Reporting Owner

Vyome Holdings Inc. held annual shareholder meeting

Vyome Holdings Inc. held annual stockholder meeting

Vyome Holdings Inc. Announces Date for Upcoming Annual Stockholders Meeting

Vyome Holdings Coverage Assumed by Maxim Group at Buy vs Previous Rating of Hold

Vyome Holdings upgraded to Buy from Hold at Maxim

Vyome Holdings Buys AI-Startup Oculo

MT Newswires Live

BRIEF-Vyome Holdings Acquires MIT AI Spinout Oculo Health

Vyome Holdings Acquires Mit AI Spinout Oculo Health

THOMSON REUTERS

Vyome Stock (HIND) Rockets on Uveitis Study Data

Vyome Holdings presents results from VT-1908 preclinical studies

Vyome Holdings Inc. Files Initial Statement of Beneficial Ownership for Director and CEO Venkateswarlu Nelabhotla

Vyome Holdings Inc. Files Initial Beneficial Ownership Statement for CFO Robert Dickey

BRIEF-Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies

Vyome Holdings Inc. Strengthens Leadership Team with New CTO and SVP Appointments Amid Pivotal Trial Preparations

Vyome Holdings Strengthens Leadership Team With Industry Veterans as It Plans Pivotal Trial Studies

THOMSON REUTERS

Vyome Holdings Inc: Vt-1953 Continues to Significantly Improve Primary Endpoint

THOMSON REUTERS

Vyome Holdings Inc: Positive Interim Data From Phase 2 Study of Vt-1953 in Malignant Fungating Wounds

THOMSON REUTERS

Vyome Holdings Announces Promising Interim Results from Phase 2 Study of VT-1953 for Malignant Fungating Wounds, Highlights $1B Market Opportunity

Vyome Holdings Inc. Completes Merger and Begins Trading on Nasdaq Under New Ticker "HIND

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/HIND/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HIND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIND\",,,,,undefined,":{"symbol":"HIND","market":"US","secType":"STK","nameCN":"Vyome Holdings, Inc.","latestPrice":2.2,"timestamp":1770066000000,"preClose":1.92,"halted":0,"volume":1346994,"hourTrading":{"tag":"盘前","latestPrice":2.17,"preClose":2.2,"latestTime":"04:20 EST","volume":120,"amount":259.850004,"timestamp":1770110409919,"change":-0.03,"changeRate":-0.013636,"amplitude":0.004545},"delay":0,"changeRate":0.14583333333333348,"floatShares":3099100,"shares":5644494,"eps":-183.1419,"marketStatus":"Pre-Mkt","change":0.28,"latestTime":"02-03 04:34:59 EST","open":1.86,"high":2.2129,"low":1.75,"amount":2781238.5934542,"amplitude":0.241094,"askPrice":2.37,"askSize":100,"bidPrice":2.16,"bidSize":1057,"shortable":3,"etf":0,"ttmEps":-183.1419,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770129000000},"marketStatusCode":1,"adr":0,"listingDate":1475726400000,"exchange":"NASDAQ","adjPreClose":2.2,"preHourTrading":{"tag":"盘前","latestPrice":2.17,"preClose":2.2,"latestTime":"04:20 EST","volume":120,"amount":259.850004,"timestamp":1770110409919,"change":-0.03,"changeRate":-0.013636,"amplitude":0.004545},"postHourTrading":{"tag":"盘后","latestPrice":2.1114,"preClose":2.2,"latestTime":"19:59 EST","volume":18963,"amount":40778.1664,"timestamp":1770080358742,"change":-0.0886,"changeRate":-0.040273,"amplitude":0.040909},"volumeRatio":0.14554397785119194},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIND\",,,,,undefined,":{"symbol":"HIND","floatShares":3099100,"roa":"-24.52%","roe":"--","lyrEps":-0.76459,"volumeRatio":0.14554397785119194,"shares":5644494,"dividePrice":0,"high":2.2129,"amplitude":0.241094,"preClose":1.92,"low":1.75,"week52Low":1.75,"pbRate":"4.91","psRate":"36.04","week52High":376.5,"institutionHeld":0,"latestPrice":2.2,"committee":0.827139,"eps":-183.1419,"divideRate":0,"volume":1346994,"delay":0,"ttmEps":-183.1419,"open":1.86,"prevYearClose":3.44,"prevWeekClose":1.92,"prevMonthClose":1.92,"prevQuarterClose":3.44,"fiveDayClose":3.11,"twentyDayClose":3.55,"sixtyDayClose":6.17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HIND\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"HIND","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":-3.12},{"market":"US","date":"2025-08-15","symbol":"HIND","defaultRemindTime":1755264600000,"type":"split","dateTimestamp":1755230400000,"forFactor":4,"toFactor":1,"ratio":4},{"market":"US","date":"2025-08-14","symbol":"HIND","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-2.25},{"market":"US","date":"2025-05-21","symbol":"HIND","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747800000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-05-09","symbol":"HIND","defaultRemindTime":1746797400000,"type":"split","dateTimestamp":1746763200000,"forFactor":25,"toFactor":1,"ratio":25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HIND\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HIND\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1763701200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HIND\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HIND","date":"2026-01-30","current":-0.012013,"percent":0.90991,"low":-23.816091,"twenty":-20.511156,"median":-6.2932,"eighty":-1.940481,"high":-0.001601,"avg":-10.383102,"sd":8.919392,"marketCap":12079217},"quantilePoints":[{"date":"2025-08-22","current":-12.854344,"twenty":-12.392244,"median":-11.699095,"eighty":-11.005946,"marketCap":20748595},{"date":"2025-08-29","current":-11.259279,"twenty":-13.22027,"median":-12.854344,"eighty":-11.500884,"marketCap":18173952},{"date":"2025-09-05","current":-9.124707,"twenty":-13.182739,"median":-11.259279,"eighty":-10.03366,"marketCap":14728473},{"date":"2025-09-12","current":-0.001997,"twenty":-12.854344,"median":-10.288753,"eighty":-0.00213,"marketCap":2910},{"date":"2025-09-19","current":-0.001751,"twenty":-12.467306,"median":-9.124707,"eighty":-0.001933,"marketCap":2551},{"date":"2025-09-26","current":-20.664803,"twenty":-13.499407,"median":-10.288753,"eighty":-0.001997,"marketCap":30109879},{"date":"2025-10-03","current":-20.473816,"twenty":-20.473816,"median":-11.259279,"eighty":-0.002098,"marketCap":29831599},{"date":"2025-10-10","current":-21.00858,"twenty":-21.00858,"median":-13.018541,"eighty":-0.002106,"marketCap":30610783},{"date":"2025-10-17","current":-19.327894,"twenty":-20.855791,"median":-13.499407,"eighty":-0.00213,"marketCap":28161920},{"date":"2025-10-24","current":-20.850495,"twenty":-20.850495,"median":-19.346992,"eighty":-0.002143,"marketCap":30380443},{"date":"2025-10-31","current":-21.039016,"twenty":-20.850495,"median":-19.786263,"eighty":-9.124707,"marketCap":30655130},{"date":"2025-11-07","current":-21.340651,"twenty":-21.039016,"median":-20.206435,"eighty":-10.010203,"marketCap":31094630},{"date":"2025-11-14","current":-18.588235,"twenty":-21.00858,"median":-20.168237,"eighty":-10.03366,"marketCap":27084192},{"date":"2025-11-21","current":-17.984966,"twenty":-21.00858,"median":-20.037322,"eighty":-10.543846,"marketCap":26205192},{"date":"2025-11-28","current":-3.129419,"twenty":-20.886349,"median":-19.767164,"eighty":-7.929274,"marketCap":29238478},{"date":"2025-12-05","current":-3.075047,"twenty":-20.851554,"median":-19.327894,"eighty":-3.104045,"marketCap":28730474},{"date":"2025-12-12","current":-2.881724,"twenty":-20.850495,"median":-18.663643,"eighty":-3.026716,"marketCap":26924236},{"date":"2025-12-19","current":-2.342231,"twenty":-20.820331,"median":-18.362009,"eighty":-2.975968,"marketCap":21883703},{"date":"2025-12-26","current":-2.271547,"twenty":-20.790168,"median":-17.381696,"eighty":-2.665444,"marketCap":21223297},{"date":"2026-01-02","current":-2.078224,"twenty":-20.744922,"median":-13.229653,"eighty":-2.363376,"marketCap":19417059},{"date":"2026-01-09","current":-2.072183,"twenty":-20.685727,"median":-12.660825,"eighty":-2.260673,"marketCap":19360614},{"date":"2026-01-16","current":-1.866777,"twenty":-20.618426,"median":-10.790143,"eighty":-2.104806,"marketCap":17441486},{"date":"2026-01-23","current":-1.761053,"twenty":-20.541319,"median":-10.03366,"eighty":-2.062517,"marketCap":16453700},{"date":"2026-01-30","current":-1.292849,"twenty":-20.511156,"median":-6.2932,"eighty":-1.940481,"marketCap":12079217}],"updateTime":1770110273960},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HIND\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584601605","title":"Vyome Holdings Inc. Files Initial Beneficial Ownership Statement; Director Shiladitya Sengupta Named as Reporting Owner","url":"https://stock-news.laohu8.com/highlight/detail?id=2584601605","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584601605?lang=en_us&edition=fundamental","pubTime":"2025-11-18 08:36","pubTimestamp":1763426170,"startTime":"0","endTime":"0","summary":"Vyome Holdings Inc. has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing lists Shiladitya Sengupta as the beneficial owner in the capacity of Director. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyome Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 17, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL3t8tPs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIND","BK4007","BK4082"],"gpt_icon":0},{"id":"2580730368","title":"Vyome Holdings Inc. held annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2580730368","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580730368?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:04","pubTimestamp":1762265059,"startTime":"0","endTime":"0","summary":"Vyome Holdings Inc. held its annual shareholder meeting on October 28, 2025. All three Class I directors, Krishna K. Gupta, Shiladitya Sengupta, and Stash Pomichter, were re-elected to the board. Shareholders ratified the appointment of Kreit & Chiu CPA LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. The 2025 Equity Incentive Plan was approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyome Holdings Inc. published the original content used to generate this news brief via Business Wire  on November 04, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nNDL6PRDP6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIND","BK4082"],"gpt_icon":0},{"id":"2579171453","title":"Vyome Holdings Inc. held annual stockholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2579171453","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579171453?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:03","pubTimestamp":1761854609,"startTime":"0","endTime":"0","summary":"Vyome Holdings Inc. held its 2025 Annual Meeting of Stockholders on October 28, 2025. At the meeting, Krishna K. Gupta, Shiladitya Sengupta, and Stash Pomichter were elected to the board of directors. Stockholders approved the company's 2025 Equity Incentive Plan and ratified the appointment of Kreit & Chiu CPA LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyome Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 30, 2025, and is solely responsible for the information ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL1JbzJm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","HIND"],"gpt_icon":0},{"id":"2573267579","title":"Vyome Holdings Inc. Announces Date for Upcoming Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2573267579","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573267579?lang=en_us&edition=fundamental","pubTime":"2025-10-06 18:17","pubTimestamp":1759745844,"startTime":"0","endTime":"0","summary":"Vyome Holdings Inc. has announced that it will hold its upcoming annual meeting of stockholders. At the meeting, shareholders will be asked to vote on the election of Krishna K. Gupta, Shiladitya Sengupta, and Stash Pomichter as Class I directors, each to serve until the 2028 annual meeting and until their respective successors are duly elected and qualified. Additional proposals include the approval of the Vyome Holdings, Inc. 2025 Equity Incentive Plan, ratification of the appointment of Kreit & Chiu CPA LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, and an advisory vote on the compensation of the company's named executive officers. Shareholders may also consider and vote on any other business that may properly come before the meeting.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nNDL1PMf2K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIND","BK4082"],"gpt_icon":0},{"id":"2572954847","title":"Vyome Holdings Coverage Assumed by Maxim Group at Buy vs Previous Rating of Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2572954847","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572954847?lang=en_us&edition=fundamental","pubTime":"2025-10-02 22:16","pubTimestamp":1759414560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HIND/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 02, 2025 10:16 ET (14:16 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","HIND"],"gpt_icon":0},{"id":"2572288511","title":"Vyome Holdings upgraded to Buy from Hold at Maxim","url":"https://stock-news.laohu8.com/highlight/detail?id=2572288511","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572288511?lang=en_us&edition=fundamental","pubTime":"2025-10-02 19:40","pubTimestamp":1759405207,"startTime":"0","endTime":"0","summary":"Maxim upgraded Vyome Holdings (HIND) to Buy from Hold with a $15 price target after taking over coverage of the stock. Published first on TheFly – ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vyome-holdings-upgraded-to-buy-from-hold-at-maxim-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vyome-holdings-upgraded-to-buy-from-hold-at-maxim-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","HIND"],"gpt_icon":0},{"id":"2571938021","title":"Vyome Holdings Buys AI-Startup Oculo","url":"https://stock-news.laohu8.com/highlight/detail?id=2571938021","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571938021?lang=en_us&edition=fundamental","pubTime":"2025-09-29 19:43","pubTimestamp":1759146195,"startTime":"0","endTime":"0","summary":"Vyome Holdings  said Monday it has bought substantially all the assets of AI-startup Oculo, which was launched at the Massachusetts Institute of Technology.The company said it has launched a new business unit focused on using AI to tackle inflammation, which will use Oculo's assets to develop an AI psychiatrist trained on data from both the US and India.Vyome's shares were up more than 8% in recent Monday premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4528","BK4543","BK4585","HIND","BK4551","BK4588","BK4082","BK4023","BK4587"],"gpt_icon":1},{"id":"2571387484","title":"BRIEF-Vyome Holdings Acquires MIT AI Spinout Oculo Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2571387484","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571387484?lang=en_us&edition=fundamental","pubTime":"2025-09-29 19:18","pubTimestamp":1759144708,"startTime":"0","endTime":"0","summary":"BRIEF-Vyome Holdings Acquires MIT AI Spinout Oculo HealthSept 29 (Reuters) - Vyome Holdings Inc HIND.O:VYOME HOLDINGS ACQUIRES MIT AI SPINOUT OCULO HEALTHSource text: ID:nBw4BLbfJaFurther company coverage: HIND.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nTUA7LDK2G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","HIND"],"gpt_icon":0},{"id":"2571382490","title":"Vyome Holdings Acquires Mit AI Spinout Oculo Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2571382490","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571382490?lang=en_us&edition=fundamental","pubTime":"2025-09-29 19:00","pubTimestamp":1759143600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nTUA7LDK2G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIND","BK4082"],"gpt_icon":0},{"id":"2568499997","title":"Vyome Stock (HIND) Rockets on Uveitis Study Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2568499997","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568499997?lang=en_us&edition=fundamental","pubTime":"2025-09-17 20:54","pubTimestamp":1758113692,"startTime":"0","endTime":"0","summary":"Vyome stock rocketed higher on Wednesday after the company announced results of an eye treatment study.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/vyome-stock-hind-rockets-on-uveitis-study-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/vyome-stock-hind-rockets-on-uveitis-study-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","HIND"],"gpt_icon":0},{"id":"2568498243","title":"Vyome Holdings presents results from VT-1908 preclinical studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2568498243","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568498243?lang=en_us&edition=fundamental","pubTime":"2025-09-17 19:15","pubTimestamp":1758107722,"startTime":"0","endTime":"0","summary":"Vyome Holdings (HIND) presented results from its preclinical studies investigating VT-1908 for treating uveitis at the recent Annual Meeting of the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vyome-holdings-presents-results-from-vt-1908-preclinical-studies-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vyome-holdings-presents-results-from-vt-1908-preclinical-studies-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIND","BK4585","BK4588","VT","BK4082"],"gpt_icon":0},{"id":"2566945028","title":"Vyome Holdings Inc. Files Initial Statement of Beneficial Ownership for Director and CEO Venkateswarlu Nelabhotla","url":"https://stock-news.laohu8.com/highlight/detail?id=2566945028","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566945028?lang=en_us&edition=fundamental","pubTime":"2025-09-12 09:21","pubTimestamp":1757640093,"startTime":"0","endTime":"0","summary":"Vyome Holdings Inc. filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The filing lists Venkateswarlu Nelabhotla as the beneficial owner, who holds the roles of Director, President, and CEO at the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyome Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 11, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nNDL4YQZvp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIND","BK4082"],"gpt_icon":0},{"id":"2566450749","title":"Vyome Holdings Inc. Files Initial Beneficial Ownership Statement for CFO Robert Dickey","url":"https://stock-news.laohu8.com/highlight/detail?id=2566450749","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566450749?lang=en_us&edition=fundamental","pubTime":"2025-09-12 09:21","pubTimestamp":1757640070,"startTime":"0","endTime":"0","summary":"Vyome Holdings Inc. has filed an initial statement of beneficial ownership. The filing mentions Robert Dickey IV as the beneficial owner, who holds the position of Chief Financial Officer. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyome Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nNDL3XHfSg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","HIND"],"gpt_icon":0},{"id":"2566469756","title":"BRIEF-Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2566469756","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566469756?lang=en_us&edition=fundamental","pubTime":"2025-09-09 20:35","pubTimestamp":1757421304,"startTime":"0","endTime":"0","summary":"BRIEF-Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial StudiesSept 9 (Reuters) - Vyome Holdings Inc HIND.O:VYOME HOLDINGS STRENGTHENS LEADERSHIP TEAM WITH IN","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nTUABBFBWB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIND","BK4082"],"gpt_icon":0},{"id":"2566364697","title":"Vyome Holdings Inc. Strengthens Leadership Team with New CTO and SVP Appointments Amid Pivotal Trial Preparations","url":"https://stock-news.laohu8.com/highlight/detail?id=2566364697","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566364697?lang=en_us&edition=fundamental","pubTime":"2025-09-09 20:30","pubTimestamp":1757421048,"startTime":"0","endTime":"0","summary":"Vyome Holdings Inc. has announced the appointment of Dr. Richard Fahrner as Chief Technology Officer and Dr. Tamara Agajanov as Senior Vice President of Clinical Development. Dr. Fahrner brings over 25 years of drug development experience, while Dr. Agajanov has nearly 30 years of expertise in clinical operations, particularly in oncology, immunology, and inflammation. These appointments come as Vyome plans pivotal trial studies, including a Phase 2 study in malignant fungating wounds, with results expected by October 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyome Holdings Inc. published the original content used to generate this news brief via Business Wire  on September 09, 2025, and is solely responsible for the informat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nNDLbmNPdR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","HIND"],"gpt_icon":0},{"id":"2566669785","title":"Vyome Holdings Strengthens Leadership Team With Industry Veterans as It Plans Pivotal Trial Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2566669785","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566669785?lang=en_us&edition=fundamental","pubTime":"2025-09-09 20:30","pubTimestamp":1757421002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nTUABBFBWB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIND","BK4082"],"gpt_icon":0},{"id":"2564374739","title":"Vyome Holdings Inc: Vt-1953 Continues to Significantly Improve Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2564374739","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564374739?lang=en_us&edition=fundamental","pubTime":"2025-09-04 20:31","pubTimestamp":1756989085,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nFWN3UR09R:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIND","BK4082"],"gpt_icon":0},{"id":"2564337475","title":"Vyome Holdings Inc: Positive Interim Data From Phase 2 Study of Vt-1953 in Malignant Fungating Wounds","url":"https://stock-news.laohu8.com/highlight/detail?id=2564337475","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564337475?lang=en_us&edition=fundamental","pubTime":"2025-09-04 20:31","pubTimestamp":1756989085,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nFWN3UR09R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIND","BK4082"],"gpt_icon":0},{"id":"2564374798","title":"Vyome Holdings Announces Promising Interim Results from Phase 2 Study of VT-1953 for Malignant Fungating Wounds, Highlights $1B Market Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2564374798","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564374798?lang=en_us&edition=fundamental","pubTime":"2025-09-04 20:31","pubTimestamp":1756989072,"startTime":"0","endTime":"0","summary":"Vyome Holdings Announces Promising Interim Results from Phase 2 Study of VT-1953 for Malignant Fungating Wounds, Highlights $1B Market Opportunity. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyome Holdings Inc. published the original content used to generate this news brief via Business Wire  on September 04, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nNDL82JHNs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIND","BK4082"],"gpt_icon":0},{"id":"2564745804","title":"Vyome Holdings Inc. Completes Merger and Begins Trading on Nasdaq Under New Ticker \"HIND","url":"https://stock-news.laohu8.com/highlight/detail?id=2564745804","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564745804?lang=en_us&edition=fundamental","pubTime":"2025-09-02 20:06","pubTimestamp":1756814797,"startTime":"0","endTime":"0","summary":"Vyome Holdings, Inc. has undergone a significant transition following the resignation of ReShape's Board of Directors and management team. The new Board and management team from Vyome have been installed, and the company has been successfully listed on the Nasdaq exchange. As part of this merger, ReShape has been renamed Vyome Holdings, Inc.  and will now focus on advancing its immuno-inflammatory assets and exploring opportunities within the US-Indian innovation corridor. Additionally, the company announced the issuance of 376,256 common shares to consultants, advisors, and for terminating a share subscription agreement. Three put/call option agreements have also been established, including one involving the exchange of shares between Indian stockholders and VHI common stock.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for information","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nNDLBK1tr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIND","BK4082"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":62,"code":"91000000","status":"200"}]}}